Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network
急性肺损伤的预防和早期治疗临床试验网络
基本信息
- 批准号:9063082
- 负责人:
- 金额:$ 37.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-17 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Lung InjuryAdult Respiratory Distress SyndromeAffectBiologicalClinicalClinical DataClinical TrialsClinical Trials NetworkCollectionData AnalysesData CollectionData QualityDevicesEarly treatmentGenderGenerationsGeneticGenomicsGoalsHealthHospitalsLeadershipMethodsMorbidity - disease rateNational Heart, Lung, and Blood InstitutePatient RecruitmentsPatient-Focused OutcomesPneumoniaPreventionProceduresProcessProteomicsProtocols documentationPublicationsRecruitment ActivityResearch PersonnelSamplingSepsisSpecimenStructureTechniquesTestingTraumaUnited States National Institutes of HealthWorkdrug testingimprovedimproved outcomeinnovationmembermicrobiomemortalitynoveloperationpreventprotocol development
项目摘要
DESCRIPTION (provided by applicant): The objective of this proposal is to support the operation of the NIH NHLBI prevention and early treatment of acute lung injury (PETAL) Network> The Network's goal is to efficiently test drugs, devices, and protocols to prevent and treat early acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) thereby improving the short and long-term outcomes of patients. To achieve this goal the investigators will:
1. Provide organizational leadership to a Steering Committee and Subcommittees to establish an orderly, rational, process to develop, select, and conduct at least two clinical trials and to refine the Network's structure, and operating procedures.
2. Collaborate in the generation of hypotheses, development of protocols, and refinement of recruitment and data collection techniques and methods to acquire and analyze clinical data and samples. This effort will include collection of high quality biological and genetic specimens to allow Network members and others outside the network to study the genomics, proteomics and microbiome of acute lung injury.
3. Over 5.5 years recruit a minimum of 220, gender and ethnically representative subjects to clinical trials to generate quality data to test hypotheses posed by the Steering Committee.
4. Disseminate study results through high profile scientific publications and presentations.
描述(由申请人提供):本提案的目的是支持NIH NHLBI急性肺损伤预防和早期治疗(PETAL)网络>的运作,该网络的目标是有效地测试药物、设备和方案,以预防和治疗早期急性肺损伤(ALI)和急性呼吸窘迫综合征(ARDS),从而改善患者的短期和长期预后。为实现这一目标,调查人员将:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TODD W RICE其他文献
A PHARMACIST-LED INTERVENTION TO INCREASE INHALER ACCESS AND REDUCE HOSPITAL READMISSION (PILLAR)
- DOI:
10.1016/j.chest.2024.06.2824 - 发表时间:
2024-10-01 - 期刊:
- 影响因子:
- 作者:
TATE PARROTT;SARAH H EBLE;KRISTINA NIEHOFF;MATTHEW WALLACE;YUE GAO;LEENA CHOI;MARY DEAR;TODD W RICE;CARLA M SEVIN;NEESHA CHOMA;AUTUMN ZUCKERMAN - 通讯作者:
AUTUMN ZUCKERMAN
TODD W RICE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TODD W RICE', 18)}}的其他基金
Using real world decisions to develop a modified central IRB model
使用现实世界的决策来开发修改后的中央 IRB 模型
- 批准号:
8840421 - 财政年份:2014
- 资助金额:
$ 37.7万 - 项目类别:
Using real world decisions to develop a modified central IRB model
使用现实世界的决策来开发修改后的中央 IRB 模型
- 批准号:
8927057 - 财政年份:2014
- 资助金额:
$ 37.7万 - 项目类别:
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis
瓜氨酸预防或减轻严重脓毒症的急性肺损伤
- 批准号:
8610942 - 财政年份:2012
- 资助金额:
$ 37.7万 - 项目类别:
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis
瓜氨酸预防或减轻严重脓毒症的急性肺损伤
- 批准号:
8240853 - 财政年份:2012
- 资助金额:
$ 37.7万 - 项目类别:
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis
瓜氨酸预防或减轻严重脓毒症的急性肺损伤
- 批准号:
8424973 - 财政年份:2012
- 资助金额:
$ 37.7万 - 项目类别:
Attenuating Inflammation via Protein-Calorie Restriction
通过限制蛋白质热量减轻炎症
- 批准号:
7913067 - 财政年份:2006
- 资助金额:
$ 37.7万 - 项目类别:
Attenuating Inflammation via Protein-Calorie Restriction
通过限制蛋白质热量减轻炎症
- 批准号:
7475149 - 财政年份:2006
- 资助金额:
$ 37.7万 - 项目类别:
Attenuating Inflammation via Protein-Calorie Restriction
通过限制蛋白质热量减轻炎症
- 批准号:
7294344 - 财政年份:2006
- 资助金额:
$ 37.7万 - 项目类别:
Attenuating Inflammation via Protein-Calorie Restriction
通过限制蛋白质热量减轻炎症
- 批准号:
7133071 - 财政年份:2006
- 资助金额:
$ 37.7万 - 项目类别:
Attenuating Inflammation via Protein-Calorie Restriction
通过限制蛋白质热量减轻炎症
- 批准号:
7666915 - 财政年份:2006
- 资助金额:
$ 37.7万 - 项目类别:
相似海外基金
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
- 批准号:
6564818 - 财政年份:2001
- 资助金额:
$ 37.7万 - 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
- 批准号:
6410976 - 财政年份:2000
- 资助金额:
$ 37.7万 - 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
- 批准号:
6418789 - 财政年份:2000
- 资助金额:
$ 37.7万 - 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
- 批准号:
6302122 - 财政年份:1999
- 资助金额:
$ 37.7万 - 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
- 批准号:
6309780 - 财政年份:1999
- 资助金额:
$ 37.7万 - 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
- 批准号:
6109540 - 财政年份:1998
- 资助金额:
$ 37.7万 - 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
- 批准号:
6265845 - 财政年份:1998
- 资助金额:
$ 37.7万 - 项目类别:














{{item.name}}会员




